Cite
Facing the Challenges in the COVID-19 Pandemic Era: From Standard Treatments to the Umbilical Cord-Derived Mesenchymal Stromal Cells as a New Therapeutic Strategy
MLA
Eleonora Russo, et al. “Facing the Challenges in the COVID-19 Pandemic Era: From Standard Treatments to the Umbilical Cord-Derived Mesenchymal Stromal Cells as a New Therapeutic Strategy.” Cells, vol. 12, no. 12, June 2023, p. 1664. EBSCOhost, https://doi.org/10.3390/cells12121664.
APA
Eleonora Russo, Simona Corrao, Francesca Di Gaudio, Giusi Alberti, Martin Caprnda, Peter Kubatka, Peter Kruzliak, Vitale Miceli, Pier Giulio Conaldi, Cesario Venturina Borlongan, & Giampiero La Rocca. (2023). Facing the Challenges in the COVID-19 Pandemic Era: From Standard Treatments to the Umbilical Cord-Derived Mesenchymal Stromal Cells as a New Therapeutic Strategy. Cells, 12(12), 1664. https://doi.org/10.3390/cells12121664
Chicago
Eleonora Russo, Simona Corrao, Francesca Di Gaudio, Giusi Alberti, Martin Caprnda, Peter Kubatka, Peter Kruzliak, et al. 2023. “Facing the Challenges in the COVID-19 Pandemic Era: From Standard Treatments to the Umbilical Cord-Derived Mesenchymal Stromal Cells as a New Therapeutic Strategy.” Cells 12 (12): 1664. doi:10.3390/cells12121664.